Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1975 2
1976 1
1977 2
1978 2
1984 1
1989 1
1990 1
1991 1
1992 1
1993 2
1994 1
1996 3
1998 1
2001 7
2002 4
2003 3
2004 7
2005 7
2006 5
2007 2
2008 6
2009 2
2010 4
2011 5
2012 11
2013 9
2014 11
2015 8
2016 7
2017 7
2018 16
2019 9
2020 8
2021 11
2022 12
Text availability
Article attribute
Article type
Publication date

Search Results

163 results
Results by year
Filters applied: . Clear all
Page 1
Discovery of 5-{4-[(7-Ethyl-6-oxo-5,6-dihydro-1,5-naphthyridin-3-yl)methyl]piperazin-1-yl}-N-methylpyridine-2-carboxamide (AZD5305): A PARP1-DNA Trapper with High Selectivity for PARP1 over PARP2 and Other PARPs.
Johannes JW, Balazs A, Barratt D, Bista M, Chuba MD, Cosulich S, Critchlow SE, Degorce SL, Di Fruscia P, Edmondson SD, Embrey K, Fawell S, Ghosh A, Gill SJ, Gunnarsson A, Hande SM, Heightman TD, Hemsley P, Illuzzi G, Lane J, Larner C, Leo E, Liu L, Madin A, Martin S, McWilliams L, O'Connor MJ, Orme JP, Pachl F, Packer MJ, Pei X, Pike A, Schimpl M, She H, Staniszewska AD, Talbot V, Underwood E, Varnes JG, Xue L, Yao T, Zhang K, Zhang AX, Zheng X. Johannes JW, et al. Among authors: barratt d. J Med Chem. 2021 Oct 14;64(19):14498-14512. doi: 10.1021/acs.jmedchem.1c01012. Epub 2021 Sep 27. J Med Chem. 2021. PMID: 34570508
Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor.
Rodrik-Outmezguine VS, Okaniwa M, Yao Z, Novotny CJ, McWhirter C, Banaji A, Won H, Wong W, Berger M, de Stanchina E, Barratt DG, Cosulich S, Klinowska T, Rosen N, Shokat KM. Rodrik-Outmezguine VS, et al. Among authors: barratt dg. Nature. 2016 Jun 9;534(7606):272-6. doi: 10.1038/nature17963. Epub 2016 May 18. Nature. 2016. PMID: 27279227 Free PMC article.
Pharmacogenetics of opioids.
Somogyi AA, Barratt DT, Coller JK. Somogyi AA, et al. Among authors: barratt dt. Clin Pharmacol Ther. 2007 Mar;81(3):429-44. doi: 10.1038/sj.clpt.6100095. Clin Pharmacol Ther. 2007. PMID: 17339873 Review.
Pharmacogenomics of methadone maintenance treatment.
Somogyi AA, Barratt DT, Ali RL, Coller JK. Somogyi AA, et al. Among authors: barratt dt. Pharmacogenomics. 2014 May;15(7):1007-27. doi: 10.2217/pgs.14.56. Pharmacogenomics. 2014. PMID: 24956254 Review.
Introducing the Neurology Milestones 2.0.
Dewey JJ, Chiota-McCollum N, Barratt D, Edgar L, Gutmann L, Shelgikar AV, Ward J, Kilgore SM; Neurology Milestones 2.0 Work Group. Dewey JJ, et al. Among authors: barratt d. Neurology. 2022 Mar 1;98(9):366-372. doi: 10.1212/WNL.0000000000013312. Epub 2022 Jan 11. Neurology. 2022. PMID: 35017311 No abstract available.
Mapping PSA density to outcome of MRI-based active surveillance for prostate cancer through joint longitudinal-survival models.
Stavrinides V, Papageorgiou G, Danks D, Giganti F, Pashayan N, Trock B, Freeman A, Hu Y, Whitaker H, Allen C, Kirkham A, Punwani S, Sonn G, Barratt D, Emberton M, Moore CM. Stavrinides V, et al. Among authors: barratt d. Prostate Cancer Prostatic Dis. 2021 Dec;24(4):1028-1031. doi: 10.1038/s41391-021-00373-w. Epub 2021 May 6. Prostate Cancer Prostatic Dis. 2021. PMID: 33958731 Free PMC article. No abstract available.
Pharmacogenetics of opioid response.
Somogyi AA, Coller JK, Barratt DT. Somogyi AA, et al. Among authors: barratt dt. Clin Pharmacol Ther. 2015 Feb;97(2):125-7. doi: 10.1002/cpt.23. Epub 2014 Dec 9. Clin Pharmacol Ther. 2015. PMID: 25670515
163 results